Food and Drug Law Institute
FDA’s 2016 New Dietary Ingredient Draft Guidance: Promise and Challenge for Dietary Supplement Innovation
January/February 2017
On August 12, 2016, FDA issued a new Draft Guidance (Draft Guidance) on its interpretation of the New Dietary Ingredient (NDI) notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act (FDCA). The Draft Guidance contains provisions that have the potential both to facilitate and to impede innovation in the dietary supplement and functional food industries.
Contacts
Capabilities
Suggested News & Insights
Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 2027Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027GMP 2026: Regulatory Reliance, AI, and the Future of Pharmaceutical ManufacturingWednesday, December 2, 2026Sidley Represents Sino Biopharmaceutical in its US$7 Billion Licensing Agreement With Boehringer IngelheimNovember 9, 2026Sidley Celebrated as the “Law Firm of the Year” in Two Areas by Best Lawyers: FDA Law and Securities RegulationNovember 5, 2026Sidley Represents Laza Medical in Its US$160 Million Series B Financing RoundNovember 4, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory
